DocGo Inc (NASDAQ:DCGO)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 0.98. At the close of trading, the stock’s price was $4.08, to imply a decrease of -0.73% or -$0.03 in intraday trading. The DCGO share’s 52-week high remains $5.74, putting it -40.69% down since that peak but still an impressive 32.6% since price per share fell to its 52-week low of $2.75. The company has a valuation of $416.37M, with an average of 0.52 million shares in intraday trading volume over the past 10 days and average of 551.29K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for DocGo Inc (DCGO), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give DCGO a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.21.
DocGo Inc (NASDAQ:DCGO) trade information
After registering a -0.73% downside in the last session, DocGo Inc (DCGO) has traded red over the past five days. The 5-day price performance for the stock is -5.77%, and 11.78% over 30 days. With these gigs, the year-to-date price performance is -27.01%. Short interest in DocGo Inc (NASDAQ:DCGO) saw shorts transact 6.5 million shares and set a 10.12 days time to cover.
The extremes give us $5 and $11 for target low and target high price respectively. As such, DCGO has been trading -169.61% off suggested target high and -22.55% from its likely low.
DocGo Inc (DCGO) estimates and forecasts
Looking at statistics comparing DocGo Inc share performance against respective industry, we note that the company has outperformed competitors. DocGo Inc (DCGO) shares are 31.19% up over the last 6 months, with its year-to-date growth rate higher than industry average at 400.00% against 7.70%. The rating firms project that company’s revenue will grow 0.14% compared to the previous financial year.
Revenue forecast for the current quarter as set by 7 analysts is 129.42M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 111.93M.Earnings reports from the last fiscal year show that sales brought in 199.25M and 192.09M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -35.04% before dropping -41.73% in the following quarter.
DCGO Dividends
DocGo Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
DocGo Inc (NASDAQ:DCGO)’s Major holders
DocGo Inc insiders hold 7.39% of total outstanding shares, with institutional holders owning 54.95% of the shares at 59.33% float percentage. In total, 54.95% institutions holds shares in the company, led by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). As of 2024-06-30, the company held over 7.2 million shares (or 6.9313% of shares), all amounting to roughly $22.24 million.
The next major institution holding the largest number of shares is BLACKROCK INC. with 7.04 million shares, or about 6.778% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $21.74 million.
